Oral rimantadine hydrochloride therapy of influenza A virus H3N2 subtype infection in adults.

In a randomized, double-blind trial involving patients with uncomplicated influenza A H3N2 subtype virus infection, rimantadine treatment (200 mg/day for 5 days) was associated with significant reductions in nasal secretion viral titers (days 2 through 4), maximal temperature (days 2 and 3), time un...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Antimicrob Agents Chemother
Hauptverfasser:	Hayden, F G, Monto, A S
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 1986
Schlagworte:	Research Article
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC176405/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3521480/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.29.2.339
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!